Foradil Aerolizer (formoterol), a new long-acting bronchodilator for asthma
April 2001
Novartis will soon launch Foradil Aerolizer (formoterol), a new long-acting bronchodilator for asthma.
It will be used as an alternative to Serevent (salmeterol).
Foradil lasts as long as Serevent. They're both used twice daily for asthma maintenance therapy.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote